SweetValueLab
Write for us

Amgen Inc. — Financial Statements & Ratios

AMGN
NASDAQHealthcareDrug Manufacturers - GeneralCIK 0000318154amgen.comAbout AMGN
Last close · Oct 16, 2026432.49−1.54 (−0.35%)
Market cap$233.8B

Key indicators

Revenue38.1BTTM+9.1% on a year earlier+6.4% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
23.7B 23.4B−1.6%25.4B+8.8%26.0B+2.2%26.3B+1.3%28.2B+7.1%33.4B+18.6%36.8B+10.0%38.1B+9.1%39.0B 40.4B 41.8B
— -1.6% 8.8% 2.2% 1.3% 7.1% 18.6% 10.0% 9.1% 6.1% 3.7% 3.3%
$12.62 $12.88+2.1%$12.31−4.4%$10.28−16.5%$12.11+17.8%$12.49+3.1%$7.56−39.5%$14.23+88.2%$16.09+31.6%$23.04 $24.51 $25.90
Profitability
43.2% 41.4%−1.8 pt35.9%−5.5 pt29.4%−6.5 pt36.3%+6.9 pt28.0%−8.3 pt21.7%−6.3 pt24.7%+3.0 pt30.0%+6.5 pt· · ·
35.3% 33.6%−1.8 pt28.6%−5.0 pt22.7%−5.9 pt24.9%+2.2 pt23.8%−1.1 pt12.2%−11.6 pt21.0%+8.7 pt23.0%+4.0 pt· · ·
67.2% 81.1%+13.9 pt77.2%−3.9 pt88.0%+10.8 pt179.0%+91.0 pt107.8%−71.2 pt69.6%−38.2 pt89.1%+19.5 pt— · · ·
Cash
10.6B 8.5B−19.2%9.9B+15.9%8.4B−15.2%8.8B+4.8%7.4B−16.2%10.4B+41.2%8.1B−22.1%10.2B−4.1%· · ·
44.5% 36.5%−7.9 pt38.9%+2.4 pt32.3%−6.6 pt33.4%+1.1 pt26.1%−7.3 pt31.1%+5.0 pt22.0%−9.1 pt26.7%−3.7 pt· · ·
3.5B 3.5B+0.1%3.8B+7.0%4.0B+6.9%4.2B+4.6%4.6B+8.6%4.8B+6.1%5.1B+6.0%— · · ·
Balance sheet
2.71x 3.09x+0.38x3.51x+0.41x4.97x+1.47x10.64x+5.67x10.37x−0.27x10.23x−0.14x6.31x−3.92x4.90x−2.66x· · ·
665.00M 609.00M−8.4%590.00M−3.1%573.00M−2.9%541.00M−5.6%538.00M−0.6%541.00M+0.6%542.00M+0.2%544.00M+0.6%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.